
Smart gels for local drug delivery to the gut
Intatct is developing an advanced materials platform to improve the way drugs are delivered and absorbed in the digestive tract. Our vision is to improve the treatment of a wide range of gastrointestinal disorders that are currently underserved. Intact Therapeutics is a Y Combinator company (Winter 2019). YC-listed status: Active.